Cargando…
Strontium ranelate treatment in a postmenopausal woman with osteonecrosis of the jaw after long-term oral bisphosphonate administration: a case report
Bisphosphonates (BPs) suppress bone resorption and increase bone strength, thus reducing the risk of fracture. Oral BPs are widely used for the prevention and treatment of osteoporosis and osteopenia. Here, we describe the case of a postmenopausal woman who took oral alendronate for >3 years for...
Autores principales: | Pan, Whei-Lin, Chen, Pi-Lun, Lin, Cho-Ying, Pan, Yi-Chun, Ju, Yuh-Ren, Chan, Chiu-Po, Hsu, Robert WW |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5513807/ https://www.ncbi.nlm.nih.gov/pubmed/28744112 http://dx.doi.org/10.2147/CIA.S141753 |
Ejemplares similares
-
Strontium ranelate in postmenopausal osteoporosis treatment: a critical appraisal
por: Cesareo, Roberto, et al.
Publicado: (2010) -
Strontium ranelate effect on bone mineral density is modified by previous bisphosphonate treatment
por: Brun, Lucas R, et al.
Publicado: (2014) -
Trajectories of Bone Remodeling Markers and Bone Mineral Density during Treatment with Strontium Ranelate in Postmenopausal Women Previously Treated with Bisphosphonates
por: Lima, Helisane, et al.
Publicado: (2014) -
Maintenance of antifracture efficacy over 10 years with strontium ranelate in postmenopausal osteoporosis
por: Reginster, J-Y., et al.
Publicado: (2011) -
Polymeric strontium ranelate nonahydrate
por: Stahl, Kenny, et al.
Publicado: (2011)